Working… Menu
Trial record 12 of 19 for:    Cenicriviroc

AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03028740
Recruitment Status : Terminated (This study was terminated early due to lack of efficacy based on the results of Part I of the AURORA study.)
First Posted : January 23, 2017
Last Update Posted : April 5, 2021
Information provided by (Responsible Party):
Tobira Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 12, 2021
Actual Study Completion Date : March 9, 2021